ZymoGenetics And Serono Report Detailed Positive Results From Atacicept Phase 1b Clinical Trial In Patients With Lupus
14th Nov 2006, 13:31 GMT
ZymoGenetics, Inc. (Nasdaq: ZGEN) and Serono (virt-x: SEO and NYSE: SRA) today presented positive results at the American College of Rheumatology (ACR) annual meeting from a Phase 1b study in systemic lupus erythematosus (SLE) patients treated with atacicept(1). The results showed that atacicept was well tolerated across all dose levels and schedules in the study. [click link for full article]
ZymoGenetics And Serono Report Detailed Positive Results From Atacicept Phase 1b Clinical Trial In Patients With Lupus related news:
- ZymoGenetics and Serono Report Detailed Positive Results From Atacicept Phase 1b Clinical Trial in Patients With Lupus — PR Newswire: All Releases
- ZymoGenetics, Serono present positive results for atacicept — Pharmaceutical Business Review Latest News
- ZymoGenetics, Serono See Positive Data — Bio-Technology News from StratCenter.com
- Human Genome Sciences Announces Positive 76-Week Results of Phase 2 Clinical Trial of LymphoStat-B(TM) in Systemic Lupus Erythematosus — PR Newswire: All Releases
- ZymoGenetics encouraged by early results on lupus treatment — bizjournals.com Health Care:Biotechnology headlines
- HGS reports positive Lupus drug test results — StratWire - Business of Healthcare NewsFeed
- Lilly drug reduces blindness in diabetic patients — Pharmaceutical Business Review Latest News
- Enbrel provides sustained clinical improvements for ankylosing spondylitis for up to 3 years — EurekAlert! - Medicine and Health
- Favrille Announces Interim Analysis of Secondary Endpoint from Pivotal Phase 3 Clinical Trial of FavId Following Rituxan in Follicular B-Cell Non-Hodgkin's Lymphoma — Bio-Technology News from StratCenter.com
- Systemic Treatment Before Surgery For Kidney Cancer Prolongs Patients' Survival — Health News from Medical News Today
Latest news from Health News from Medical News Today:
- Biotech Industry Welcomes WHO Initiative On Naming Of Biologicals Including Biosimilar Medicines
- Common Cause Of Heart Disease, Diabetes May Be Treatable With Malaria Drug
- Two Nerve Cells In Direct Contact
- Value Of 'Helper' Compound In Treating Some Leukemias
- Internists Take Home Several National Awards At AAMC Annual Meeting
- Most Canadian Med School Grads Lack Basic Surgical Skills
- ACP's Electronic Medical Resource Ranked No. 1 Evidence-based Tool By MLA's South Central Chapter
- University Of Illinois Scientist Helping Processors Keep E. Coli Out Of Meat
- American Thoracic Society Publishes New Statement On Hepatotoxicity Of Antituberculosis Therapy
- Neural Networking Nanotubes